Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degeneration

被引：0
|
作者：
Yume Kobayashi [1 ]
Maiko Maruyama-Inoue [1 ]
Tatsuya Inoue [1 ]
Yasuo Yanagi [1 ]
Kazuaki Kadonosono [1 ]
机构：
[1] Yokohama City University Medical Center,Department of Ophthalmology
来源：
BMC Ophthalmology | / 25卷 / 1期
关键词：
Age-related macular degeneration; Polypoidal choroidal vasculopathy; Anti-vascular endothelial growth factor; Brolucizumab; Subretinal fluid;
D O I：
10.1186/s12886-025-04049-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration
    Hirono, Kazushi
    Maruyama-Inoue, Maiko
    Yanagi, Yasuo
    Kadonosono, Kazuaki
    PLOS ONE, 2024, 19 (04):
  • [2] Neovascular Age-Related Macular Degeneration with Baseline 20/20 Visual Acuity: Three-Year Clinical Outcomes
    Ong, Joshua
    Nawash, Baraa
    Hwang, Jonathan
    Chen, Jeffrey
    Driban, Matthew
    Chhablani, Jay
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [3] Visual outcomes in patients with neovascular age-related macular degeneration
    Tan, Colin S.
    Ngo, Wei Kiong
    Lim, Louis W.
    ACTA OPHTHALMOLOGICA, 2018, 96 (02) : e254 - e254
  • [4] Three-year outcomes of a treat and extend regimen of aflibercept for neovascular age-related macular degeneration
    Hosokawa, Mio
    Morizane, Yuki
    Kimura, Shuhei
    Shiode, Yusuke
    Hirano, Masayuki
    Doi, Shinichiro
    Toshima, Shinji
    Takahashi, Kosuke
    Fujiwara, Atsushi
    Kanzaki, Yuki
    Hosogi, Mika
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [5] Three-year Outcomes of Treat and Extend Aflibercept Treatment for Neovascular Age-related Macular Degeneration
    Kataoka, Keiko
    Asai, Keiko
    Tsunekawa, Yuma
    Ito, Yasuki
    Terasaki, Hiroko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [6] The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration
    Musial-Kopiejka, Magdalena
    Polanowska, Katarzyna
    Dobrowolski, Dariusz
    Krysik, Katarzyna
    Wylegala, Edward
    Grabarek, Beniamin Oskar
    Lyssek-Boron, Anita
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
  • [7] Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
    Itagaki, Kanako
    Sekiryu, Tetsuju
    Kasai, Akihito
    Sugano, Yukinori
    Ogasawara, Masashi
    Saito, Masaaki
    BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [8] Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
    Kanako Itagaki
    Tetsuju Sekiryu
    Akihito Kasai
    Yukinori Sugano
    Masashi Ogasawara
    Masaaki Saito
    BMC Ophthalmology, 20
  • [9] THREE-YEAR OUTCOMES OF INTRAVITREAL AFLIBERCEPT INJECTION FOR TREATMENT NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Motoki, K.
    Yoshimi, N.
    Masayuki, O.
    Kyoko, F.
    Tomoyuki, C.
    Kazuki, N.
    Kanji, T.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) : E81 - E82
  • [10] One-year outcome of brolucizumab for neovascular age-related macular degeneration in Japanese patients
    Inoda, Satoru
    Takahashi, Hidenori
    Takahashi, Ryota
    Hashimoto, Yuto
    Yoshida, Hana
    Tsukii, Rika
    Takahashi, Hironori
    Kawashima, Hidetoshi
    Yanagi, Yasuo
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345